NCT05884606View on ClinicalTrials.gov

The Allurion Digital Behaviour Change Intervention

NACompletedINTERVENTIONAL
Enrollment

107

Participants

Timeline

Start Date

June 19, 2021

Primary Completion Date

May 6, 2022

Study Completion Date

November 6, 2022

Conditions
Obesity
Interventions
DEVICE

Allurion Digital Behaviour Change Intervention

The Allurion DBCI adheres to current National Institute for Health and Care Excellence (NICE) guidance for obesity.

Trial Locations (4)

1043

Nederlandse Obesitas Kliniek (NOK), Amsterdam

1217

Allurion Kliniek, Nederland

B74 2UG

Medizen Aesthetic Clinic, Sutton Coldfield

BR1 3RA

Monkhouse Surgical, Bromley

Sponsors
All Listed Sponsors
lead

Allurion Technologies

INDUSTRY

NCT05884606 - The Allurion Digital Behaviour Change Intervention | Biotech Hunter | Biotech Hunter